StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report released on Wednesday. The firm issued a hold rating on the stock.
China Pharma Stock Performance
CPHI opened at $0.29 on Wednesday. The stock has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.43. China Pharma has a 1 year low of $0.27 and a 1 year high of $2.18. The company has a quick ratio of 0.25, a current ratio of 0.89 and a debt-to-equity ratio of 0.17.
China Pharma (NYSE:CPHI – Get Free Report) last released its quarterly earnings data on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%. The business had revenue of $1.37 million during the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- What is the NASDAQ Stock Exchange?
- MarketBeat Week in Review – 5/20 – 5/24
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Following Congress Stock Trades
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
